Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vuk Zdinjak

IM Cannabis Revenue Grows 78% YoY, What About Debt?

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) Q3 2022 revenues were CA$14.2 million ($10.7 million), compared to CA$8.0 million on Q3 2021, an increase of 78%, representing a 12% sequential organic growth. The increase in revenues is primarily attributed to the increase in the quantity of medical cannabis products sold, as well as from the higher average selling price per gram the company realized from its portfolio of branded cannabis products in Israel.

Q3 2022 Financial Results

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.